Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $1.03 billion. The enterprise value is $209.09 million.
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NKTR has 34.21 million shares outstanding. The number of shares has increased by 83.87% in one year.
| Current Share Class | 34.21M |
| Shares Outstanding | 34.21M |
| Shares Change (YoY) | +83.87% |
| Shares Change (QoQ) | +3.40% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 89.62% |
| Float | 28.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.80 |
| Forward PS | 30.74 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.00, with a Debt / Equity ratio of 0.15.
| Current Ratio | 9.00 |
| Quick Ratio | 8.22 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.00 |
Financial Efficiency
Return on equity (ROE) is -37.92% and return on invested capital (ROIC) is -44.08%.
| Return on Equity (ROE) | -37.92% |
| Return on Assets (ROA) | -14.79% |
| Return on Invested Capital (ROIC) | -44.08% |
| Return on Capital Employed (ROCE) | -16.47% |
| Weighted Average Cost of Capital (WACC) | 12.86% |
| Revenue Per Employee | $828,333 |
| Profits Per Employee | -$2.81M |
| Employee Count | 63 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NKTR has paid $119,000 in taxes.
| Income Tax | 119,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.96% in the last 52 weeks. The beta is 1.42, so NKTR's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -49.96% |
| 50-Day Moving Average | 44.60 |
| 200-Day Moving Average | 64.97 |
| Relative Strength Index (RSI) | 23.44 |
| Average Volume (20 Days) | 656,674 |
Short Selling Information
The latest short interest is 6.77 million, so 19.78% of the outstanding shares have been sold short.
| Short Interest | 6.77M |
| Short Previous Month | 7.00M |
| Short % of Shares Out | 19.78% |
| Short % of Float | 23.65% |
| Short Ratio (days to cover) | 5.02 |
Income Statement
In the last 12 months, NKTR had revenue of $52.19 million and -$177.26 million in losses. Loss per share was -$6.31.
| Revenue | 52.19M |
| Gross Profit | 52.19M |
| Operating Income | -158.42M |
| Pretax Income | -177.14M |
| Net Income | -177.26M |
| EBITDA | -157.75M |
| EBIT | -158.42M |
| Loss Per Share | -$6.31 |
Full Income Statement Balance Sheet
The company has $952.86 million in cash and investments and $128.67 million in debt, with a net cash position of $824.19 million or $24.09 per share.
| Cash & Investments | 952.86M |
| Total Debt | 128.67M |
| Net Cash | 824.19M |
| Net Cash Per Share | $24.09 |
| Equity (Book Value) | 849.72M |
| Book Value Per Share | 24.84 |
| Working Capital | 603.86M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$256.96 million and capital expenditures -$1.23 million, giving a free cash flow of -$258.18 million.
| Operating Cash Flow | -256.96M |
| Capital Expenditures | -1.23M |
| Depreciation & Amortization | 666,000 |
| Net Borrowing | 253.06M |
| Free Cash Flow | -258.18M |
| FCF Per Share | -$7.55 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -303.57% |
| Pretax Margin | -339.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -83.87% |
| Shareholder Yield | -83.87% |
| Earnings Yield | -20.89% |
| FCF Yield | -24.99% |
Analyst Forecast
The average price target for NKTR is $131.92, which is 336.82% higher than the current price. The consensus rating is "Buy".
| Price Target | $131.92 |
| Price Target Difference | 336.82% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | -14.41% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
NKTR has an Altman Z-Score of 0.84 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.84 |
| Piotroski F-Score | 3 |